相关实验视频

Updated: Jul 11, 2025

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.2K

在间歇性肺部疾病后,成功的trastuzumab-deruxtecan可以重新挑战:一个案例报告

Vincent A de Weger1, Tim Schutte1, Inge R H M Konings1

  • 1Department of Medical Oncology, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.

Journal of breast cancer
|November 5, 2023
PubMed
概括

在2级间歇性肺病 (ILD) 后,Trastuzumab deruxtecan (T-DXd) 的重新挑战是可行的. 这种方法在乳腺癌患者中产生了临床益处和改善了生活质量.

关键词:
乳腺新生体 乳腺新生体肺部疾病,间歇性疾病重新挑战一个挑战特拉斯图祖马布可以为德鲁克斯.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function08:04

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

11.7K

相关概念视频

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
168